Balaxi Pharmaceuticals fundamental analysis
BALAXI
20.1
0.46 (-2.24%)Last updated on 20 Feb, 2026 | 15:31 IST
BUYSELL
Free Demat with Zero AMC*
Balaxi Pharmaceuticals Fundamentals
P/E Ratio
12.02
P/B Ratio
0.48
Div. Yield
0
Sector P/E
39.61
Sector P/B
2.3
Sec. Div. Yield
82.6
Balaxi Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 12.02, compared to the sector average of 39.61. Its P/B Ratio stands at 0.48, while the sector’s is 2.3. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 82.6%.
Balaxi Pharmaceuticals Score Card
Price
Expensive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Balaxi Pharmaceuticals reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Balaxi Pharmaceuticals Associated Pages
